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Abstract  
Objective: Various models exist to predict short-term risk-adjusted outcomes after cardiac 
surgery. Many models are calibrated using administrative data and are subject to controversy. 
This study describes a procedure specific risk prediction model based on administrative NHS 
Health Episode Statistics (HES) data for England and compares its performance with the 
EuroSCORE.  
Methods: Procedure specific models were built on administrative data and tested using an 
independent dataset sampled at a later period. Models are applicable to patients having 
isolated CABG, isolated valve or combined CABG and valve surgery. Outcomes at hospital 
discharge and 1 year are linked with national death registrations. Comparisons between the 
models are conducted on a local cohort of patients between 2010 and 2013 using c-statistic 
for performance and expected vs observed mortality plots to examine calibration across 
different risk strata. 
Results: A total of 84,791 patients in England and 1,174 locally were identified. HES models 
have higher or comparable predictive performance compared to the re-calibrated logistic 
EuroSCORE.  Model calibration demonstrates good performance with a median difference 
between observed and predicted mortality rates of 0.15% for CABG, 0.39% for valve and 
0.63% for CABG+Valve surgery. 
C-statistics test for risk prediction models  
 CABG CABG and valve Valve 
In-hospital 
(%) 
1-year 
(%) 
In-
hospital 
(%) 
1-year 
(%) 
In-
hospital 
(%) 
1-year 
(%) 
HES England data 81.6 78.4 76.4 72.0 78.6 77.8 
Local data 80.5 76.3 73.9 72.0 78.0 76.1 
Recalibrated logistic  
EuroSCORE 
 
78.8 
 
75.7 
 
71.6 
 
68.8 
 
71.2 
 
70.5 
 
  
 
 
3 
Conclusion: The national administrative dataset has produced and accurate short and one 
year mortality prediction after cardiac surgery.  
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Introduction 
Risk stratification is an important part of modern cardiac surgery and there are multiple 
validated risk predicting statistical models used for numerous purposes (Euroscore, loge 
euroscore, euroscore 2 and sts 3 references valve bacbg and cabg and valves). These are not 
without limitations.  Firstly, there are issues regarding their construction based upon variably 
sized datasets collected in clinical speciality specific registries. 
Although it is recognised that this approach may provide more detailed information for 
individual patients, there are a number of problem areas.  Firstly national clinical registries 
that underpin clinical audits are expensive (ref HQUP 14 million).  Secondly, once a registry 
is established, by its very nature it is unable to adapt to include emerging prognostically 
important variables. Finally, particularly when used for governance purposes (both 
institutional and individual level), given their information is usually entered by clinicians, it 
may lead to inaccuracies and bias ((J Am Coll Cardiol 2012;59:2309–16)). 
Furthermore, most risk predicting scores are modelled to predict an early end point of 
mortality.  There is debate as to exactly what constitutes such an endpoint: death in hospital, 
death within 30 days a combination of the two, and this lack of standardisation makes 
benchmarking comparisons difficult amongst different healthcare systems. 
Finally, given that most cardiac surgical procedures are performed for their perceived late 
prognostic value, there are no tools to predict such outcomes to date. 
Administrative datasets are known to have several pitfalls and have not been recommended as 
a principal datasets to construct risk-scoring systems (REF Siregar et al.).  The Hospital 
Episode Statistics (HES) dataset linked to the Office of National Statistics (ONS) provides an 
opportunity to use routinely collected patient level national data with provision to identify in 
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hospital and post-discharge long term outcome, and we have demonstrated its accuracy when 
used to create mortality based risk algorithms for a national health care system (QUORUM 
paper NBJ Open). The aim of this study was therefore to develop this methodology for 
cardiac surgery by constructing procedure specific prognostic models both for early (in-
hospital and 30 days) and up to one year and assess their performance. 
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Materials and methods 
Data Source 
Data were extracted from the National Hospital Episode Statistics (HES) dataset 
(http://www.hscic.gov.uk/hes). Mortality data were obtained from the Office of National 
Statistics and linked to HES data by the Health and Social Care Information Centre, England. 
For the purpose of this study patients were selected on the basis of having undergone isolated 
coronary artery bypass grafting (CABG), isolated valve surgery or a combined valve and 
CABG procedures (CABG+Valve). Patients having undergone aortic surgery, procedures for 
adult congenital heart disease, thoracic organ transplantation and implantation of a primary 
ventricular assist device or postinfarction VSD repair were excluded. The sample and 
independent variables i.e. the additive and logistic EuroSCOREs were extracted from the 
local cardiac surgical database.  
 
Statistical Analysis and Model development 
This study was conducted in two stages. In stage 1 HES data was used to construct models 
predicting short (in-hospital and 30 days from operation) and midterm mortality (90 days, 180 
days and 365 days from operation). The sample and independent variables for the HES 
models were derived from clinical, demographic and administrative data contained within 
NHS Health Episode Statistics (http://www.hscic.gov.uk/hesdatadictionary).  In stage 2 the 
HES based predictions were compared with the additive EuroSCORE, recalibrated 
EuroSCORE and logistic EuroSCORE.  
 
Development of HES model  
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National patient data for the financial years 1 April 2008/ 31 March 2009 to 1 April 2010/ 31 
March 2011 were extracted from HES and split 70:30 as development and test samples. The 
same procedure was repeated for the 3 clinical groupings (CABG, valve and CABG+Valve 
surgery) and for the different mortality end points (in-hospital, 30, 90, 180 and 360 
postoperative days).  A second independent dataset was extracted from HES in financial years 
2011/2012 and 2012/13 to assess the time stability of models. 
All procedures were identified using Office of Population, Censuses and Surveys taxonomy 
(OPCS codes) selected by a team of cardiac surgeons. In admissions with multiple episodes 
the earliest episode having cardiac surgery was chosen.   
Explanatory variables were selected in the year preceding the admission considering existing 
knowledge on items likely to be associated with mortality in admissions to the NHS, and 
based upon previous experience (11). The following explanatory variables were included: 
age, gender, ethnicity, deprivation score (Index of Multiple Deprivation, IMD) (Ref: Noble 
M, Wright G, Dibben C, et al. Indices of deprivation 2004. Report to the Office of the Deputy 
Prime Minister. London: Neighbourhood Renewal Unit, 2007.) hospital trust, individual 
components of the Charlson comorbidity score12, type and method of admission (determined 
on the basis of admissions ending within the specified time period), total number of previous 
emergency admissions, worst Charlson score on previous admissions, hospital length of stay 
and trust – year (identifying the patients admitted to each trust over each of the three included 
years) . The index of multiple derivation comprises of seven indicators on a scale of 0 (least 
deprivation) to 100 (highest deprivation). The individual domains and their weights are: 
Income deprivation 22.5%; Employment deprivation 22.5%; Health deprivation and disability 
13.5%; Education, skills and training deprivation 13.5%; Barriers to housing and services 
9.3%; Crime 9.3%; Living Environment deprivation 9.3%. Charlson components relating to 
acute events i.e. stroke and heart attack were excluded, as it is uncertain in the administrative 
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record whether they occur before or after the surgical intervention. Year and Month were used 
to investigate long term and seasonal time trends respectively. Models were constructed to 
predict mortality using stepwise logistic regression on a 70% development sample from April 
2008 until March 2011. After validation on the 30% test sample models were recalibrated on 
the full dataset. Individual logistic mortality models were constructed for CABG, valve and 
combined valve and CABG procedure at hospital discharge and at 30, 90 and 365 days post 
operation. 
 
Performance of HES model 
The risk models were evaluated in terms of discrimination and calibration. Discrimination 
was assessed by determining the C-Statistics, also known as the area under the receiver 
operating characteristic (ROC) curve. A C-Statistic of 100% indicates perfect discriminative 
power and 50% no discriminative ability. The Calibration was not assessed using the Hosmer-
Lemeshow test since is not informative in large sample sizes, but we constructed calibration 
plots comparing observed vs predicted mortality across different risk strata. We assesed the 
performance of the HES model within the development dataset (years 2008-2011) and on a 
yearly basis (2008-2013) for all the mortality endpoints.  
The second part of this study assessed the performance of the HES model against the 
EuroSCORE and its variants. Access to EuroSCOREs was limited to patients admitted 
locally. Additive and logistic EuroSCOREs were extracted for patients with the same medical 
profile as in stage 1 i.e. patients who received CABG, valve surgery and CABG + valve 
surgery. A recalibrated EuroSCORE (Rec-ES) (compensating for drift in the mortality 
calibration was calculated using the methodology provided by the National Institute for 
Cardiovascular Outcomes Research (Eur J Cardiothorac Surg (2014) 45 (2): 225-
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233).. HES risk scores were calculated using HES model, but may also be calculated from 
local episode tables providing prior emergency and non-emergency admissions. The final data 
set contained:  
 Additive EuroScore, Logistic EuroScore, Re-calibrated Euroscore 
 HES scores predicting In hospital, 30, 90, 180 and 365 day mortality post operation 
 ONS mortality recorded In hospital, 30, 90, 180 and 365 day mortality post operation 
from 2008/09 to 2013/14. 
C-Statistics were compared using bootstrapping (Reference: Efron b. and Tibshirani R. 1993 
and introduction to the Bootstrap. (Chapman & Hall/ CRC monographs on statistics & 
applied probability.). One thousand c-statistics were generated by sampling the original data 
with replacement and calculating the c-statistic on each sample for each score. The resultant 
dataset contains paired data and facilitates direct comparison of c-statistics  
Analyses were performed using SAS 9.2. This study has been approved by the University 
Hospitals Birmingham Clinical Governance Board (code: CARMS-00050).  
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Results 
The HES model was developed using data of patients undergoing CABG (35115), valve 
surgery (18353) and CABG+valve (8392) between 1/4/2008 and 31/3/2011 in England. In 
hospital mortality for CABG was 1.82% (650/35115), for valve surgery 3.6% (666/18353) 
and for CABG+valve 6.0% (505/8392). Patients’ summary statistics including type of cardiac 
surgery and in-hospital outcomes are described in Table 1.  The model variables to predict in 
hospital mortality are illustrated in Table 2. the remaining models predicting mortality at 30, 
90, 180 and 365 days post surgery are available in supplemental file 1. The predictive model 
for in-hospital mortality was tested also on patients undegoing surgery frorm 1./4/.2011 to 
31/.03/.2013.  
Performance statistics for the HES models for mortality in –hospital at 30, 90, 180 and 360 
days post surgery are described in Table 3 (discrimination) and Figure 1 (calibration). 
Calibration of the HES model demonstrates a small difference between observed and 
expected mortality and delivers a good estimate of risk of mortality for patients undergoing 
CABG, valve or combined CABG and valve surgery. Across the 10 risk strata and all time 
periods the median absolute difference between observed and expected mortality rates is 
0.15% for CABG, 0.39% for Valve and 0.63% for combined CABG and valve; the upper 
quartile for differences are 0.21%, 0.65% and 1.1% respectively. Analysis of In-hospital 
deaths during the developmental (2008/09, 2009/10, 2010/11) and validation periods 
(2011/12, 2012/13) shows under prediction on 2008/09 and good prediction within the bounds 
of error for remaining years on isolated CABG and valve procedures and concomitant CABG 
and valve.  Kaplan Meier survival curves post surgery are illustrated in Figure 2 (for the entire 
patient population- a, and for the 3 groups of surgery- b.) and counts of deaths post surgery in 
Table 4 ( a and b). Visual analysis indicates that that survival has improved over time. After 
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an initial sharp decline survival becomes linear after 120 days from surgery for the entire 
population and at different times for different procedures. 
 
Comparison of the HES models against the EuroSCOREs is on a much smaller sample i.e. the 
local hospital dataset with around 500 patients per year, and to compensate performance 
statistics are accumulated over five years from April 2008 until March 2013. Across all five 
years and all three sets of procedures there were 2580 patients and 88 deaths. HES surgical 
classifications as CABG, valve and combined procedures decoded from OPCS codes agree 
with surgical classification input directly into the local cardiac database; 99.8%, 99.2%, 
98.0% respectively. Comparison data of the HES model with EuroSCORE are described in 
Table 5 (discrimination) and Table 6 (calibration).  
Additional bootstrap results for the in-hospital deaths indicate the discrimination of the 
EuroSCORE variants is the same within each type of operation; CABG 81%, combined 
CABG and Valve 74%, and Valve 69%. The HES based model has the same dicrimination as 
the EuroSCORE for CABG and combined CABG and Valve procedures. HES discrimination 
of the Valve only procedure is 9.4% higher than EuroSCORE alternates. There was no 
significant difference between the HES and the Rec-ES in the local dataset. Nonetheless an 
increase in the c-stat of the Valve model from 65% to 75% lifts a predictor from being 
relatively poor to good.  
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Table 1 
Demographic characteristics of the study population for the HES model development .  
    CABG Valve CABG + Valve   
Characteristic Value Survive Die Survive Die Survive Die Value 
Gender 
Male 28,037 454 9,930 335 5,574 310 Male 
Female 6,428 196 7,757 331 2,313 195 Female 
Ethnicity 
White 27,883 509 15,184 567 6,855 420 White 
Asian 2,310 54 468 22 199 24 Asian 
Other 941 21 555 27 124 11 Other 
Unknown 3,331 66 1,480 50 709 50 Unknown 
    CABG Valve CABG + Valve   
  Value Survive Die Survive Die Survive Die Value 
Age 
20 
8 
11 
223 
5 
7 
8 
20 
25 279 25 
30 14 310 8 30 
35 70 337 8 8 35 
40 346 489 13 19 40 
45 958 642 9 60 45 
50 2,025 12 813 21 108 7 50 
55 3,188 17 1,050 27 256 9 55 
60 4,992 44 1,686 31 593 24 60 
65 6,226 77 2,325 50 992 45 65 
70 6,399 116 2,660 101 1,481 82 70 
75 6,080 173 2,946 149 1,990 131 75 
80 3,244 128 2,273 142 1,593 117 80 
85 852 66 1,238 72 673 71 85 
90 
60 6 
366 24 
107 11 
90 
95 50 6 95 
    CABG Valve CABG + Valve   
  Value Survive Die Survive Die Survive Die Value 
IMD 
0 - 10 12,187 212 7,106 250 3,186 190 0 - 10 
11 - 20 9,569 179 5,056 178 2,208 152 11 - 20 
21 - 40 8,634 176 3,820 145 1,746 109 21 - 40 
41 - 60 3,382 74 1,405 74 610 49 41 - 60 
61 + 693 9 300 19 137 5 61 + 
    CABG Valve CABG + Valve   
  Value Survive Die Survive Die Survive Die Value 
Current 
Admission 
Elective 22,772 278 14,507 392 6,014 298 Elective 
Emergency 4,246 185 1,450 147 689 96 Emergency 
Other 7,447 187 1,730 127 1,184 111 Other 
Emergency 
Admissions 
ending within 
365 days 
0 22147 371 11717 353 5221 285 0 
1 8836 171 3811 152 1808 127 1 
2 2355 64 1339 74 551 51 2 
3+ 1127 44 820 87 307 42 3+ 
Other 
Admissions 
ending within 
365 days 
0 11300 305 3849 197 1655 161 0 
1 15433 181 7729 211 3686 178 1 
2 5220 103 3981 130 1671 92 2 
3 1621 38 1301 79 573 41 3 
4+ 891 23 827 49 302 33 4+ 
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Table 2 Comparison of models to predict in-hospital mortality 
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  CABG Valve CABG + Valve 
Effect Level Estimate Probt Estimate Probt Estimate Probt 
Intercept   -4.928 <.0001 -4.471 <.0001 -3.570 <.0001 
Gender 
Male 0.000   -0.308 0.000 -0.398 0.000 
Female 0.257 0.005 0.000   0.000   
Age (B-Spline) 
Age_0 2.766 0.008 -0.127 0.665 0.935 0.596 
Age_1 -2.632 <.0001 0.000   -0.513 0.494 
Age_2 0.000   1.334 <.0001 0.000   
Age_3 0.924 0.001     0.483 0.068 
Age_4 1.816 <.0001     0.641 0.034 
Age_5         2.108 0.020 
Ethnicity 
Unknown 0.176 0.203         
Other 0.381 0.080         
Asian 0.410 0.007         
White 0.000           
CHF 
Yes 1.413 <.0001 1.232 <.0001 1.150 <.0001 
No 0.000   0.000   0.000   
LvDis 
Yes 3.256 <.0001 2.595 <.0001 3.608 <.0001 
No 0.000   0.000   0.000   
RenDis 
Yes 0.805 <.0001 1.132 <.0001 0.792 <.0001 
No 0.000   0.000   0.000   
PVD 
Yes 0.631 <.0001     0.329 0.023 
No 0.000       0.000   
PeUl 
Yes         1.026 0.002 
No         0.000   
CHF*RenDis 
CHF = Y ; 
RenDis = 
Y     -0.473 0.018     
CHF = Y ; 
RenDis = 
N     0.000       
CHF = N ; 
RenDis = 
Y     0.000       
CHF = N ; 
RenDis = 
N     0.000       
Current Admission 
Other 0.314 0.003 0.512 <.0001 0.224 0.096 
Emergenc
y 0.769 <.0001 0.694 <.0001 0.635 <.0001 
Elective 0.000   0.000   0.000   
Emergency Admissions in 
last Year 
3+ 0.744 <.0001         
2 0.312 0.038         
1 0.217 0.022         
0 0.000           
Other Admissions in Last 
year 
4+ 0.200 0.370         
3 -0.007 0.973         
2 0.046 0.717         
1 -0.251 0.015         
0 0.000           
Other Admissions in the 
last 3 Months (91 days) 
2+         0.331 0.057 
1         -0.195 0.095 
0         0.000   
Days in hospital from 
admissions ending in the 
Last Year       0.017 <.0001 0.014 0.004 
No_History       0.429 0.001     
Age B-Spline Details   
Degree = 2 ; Min = 19 ; 
Max = 94 ; Knots = 62, 
67 
Degree = 1 ; Min = 18 
; Max = 99 ; Knots = 
60 
Degree = 2 ; Min = 18 ; 
Max = 99 ; Knots = 60, 
74, 81 
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Unk= Unknown; CHF = congestive heart failure; PeUl= Peptic ulcer; PVD=Peripheral 
Vascular Disease; 
 
Table  providing details of the In Hospital mortality models on a loge odds scale. Parameters 
for each model have been aligned to compare which terms are included and excluded within 
each model. All classification levels are included for each factor. Reference levels are 
identified in the table as having a zero estimate and no associated p-value. Continuous factors 
e.g. Age are incorporated using B-Splines and have similar form/shape to the mortality rates 
in Table 1. Interaction terms are indicated by the * between the two candidate variables.  
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Table 3 
Discrimination of the HES models (C- Statistics, %) 
    Development statistics 
                   Yearly 
Performance 
 
Mode
l 
Mortality 
Developmen
t 
(%) 
Testin
g 
(%) 
Combine
d 
(%) 
2008/09 
(%) 
2009/10 
(%) 
2010/11 
(%) 
2011/1
2 
(%) 
2012/1
3 
(%) 
C
A
B
G
 
In-
hospital 
81.8 81.4 81.6 
72.4 78.6 80.8 83.4 82.4 
30 days 80.0 78.6 79.6 68.9 77.6 79.4 79.5 77.7 
90 days 80.6 79.9 80.4 70.5 78.2 80.1 79.9 77.3 
180 days 79.7 79.1 79.5 70.5 76.9 79.8 78.6 76.7 
365 days 78.9 77.3 78.4 70.5 76.7 78.4 77.5 76.9 
V
al
v
e 
In-
hospital 
79.0 77.6 78.6 
68.0 79.6 75.0 78.5 76.0 
30 days 76.5 77.6 76.8 66.5 77.2 71.7 77.1 73.3 
90 days 77.9 77.2 77.7 68.8 78.0 74.2 75.6 74.4 
180 days 78.3 77.1 78.0 69.3 78.0 74.1 75.6 74.0 
365 days 78.1 77.0 77.8 69.0 77.1 74.5 75.6 74.1 
C
A
B
G
 +
 V
al
v
e 
In-
hospital 
77.8 73.1 76.4 
61.8 74.0 75.8 74.9 74.7 
30 days 75.7 69.7 73.9 63.3 71.1 72.3 72.0 73.8 
90 days 75.6 69.9 73.9 66.0 71.8 72.8 72.8 73.1 
180 days 74.7 69.6 73.1 66.2 71.6 71.9 71.9 71.9 
365 days 73.4 69.0 72.0 66.2 71.1 71.0 71.1 71.8 
CABG= Coronary Artery Bypass Grafting; % indicates the C-Stats area under the  ROC curve; 
.  
The C-statistics of the HES model applied to three procedure groups (CABG, valve, CABG 
and valve) demonstrates a good performance up to one year post surgery. Extended testing to 
patients undergoing surgery in subsequent financial years (2011/2012 and 2012/2013) shows 
that the models maintained performance outside of the development period.  
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Figure 1. 
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Legend to Figure 1. 
Calibration plot of the HES risk prediction models. Panel A:  observed vs. expected risk of 
mortality (±95% confidence interval) for risk strata of the HES models. Panel B: year by year 
calibration for In-hospital deaths.  
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Figure 2 a.  Survival from operation for all groups  
 
 
 
 
Figure 2 b. Survival by procedure 
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Legend to Figure 2 (a and b). 
 
a. Kaplan Meier survival plot for all patients undergone surgery between finacial years 
2008-2013. Note the accelerated survival becomes linear at 120 days post surgery. 
 
b. Kaplan Meiar survival plot for all patients undergone surgery between finacial years 
2008-2013 grouped by the 3 procedure . 
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Table 4 a:  Count of deaths over time following different operations 
Deaths Post operation aggregated from 2008 to 2013 
  CABG Valve CABG + Valve Total   
Days post 
Operation 
In 
Hospital 
Discharge
d 
In 
Hospital 
Discharg
ed 
In 
Hospital 
Discharg
ed 
In 
Hospital 
Discharg
e 
Grand 
total 
0 - 30 1296 171 1233 172 997 98 3526 441 3967 
31 - 60 119 232 161 283 112 166 392 681 1073 
61 - 90 32 218 44 227 42 139 118 584 702 
91 - 120 16 164 23 180 23 107 62 451 513 
121 - 150 4 138 9 166 5 95 18 399 417 
151 - 180 2 143 
 
145 4 72 6 360 366 
181 - 210 3 124 2 128 2 67 7 319 326 
211 - 240 2 113 3 132 2 52 7 297 304 
241 - 270 
 
126 2 139 1 62 3 327 330 
271 - 300 
 
112 1 124 
 
64 1 300 301 
301 - 330 1 109 
 
101 
 
57 1 267 268 
331 - 360 
 
107 
 
99 
 
50 
 
256 256 
Total for 
Year 1475 1757 1478 1896 1188 1029 4141 4682 8823 
 
 
 
Table 4 b:  Percentages of deaths over time following different operations 
Deaths Post operation aggregated from 2008 to 2013 
  CABG Valve CABG + Valve Total   
Days post 
Operation 
In 
Hospital Discharged 
In 
Hospital 
Discharg
ed 
In 
Hospital 
Discharge
d 
In 
Hospital 
Dischar
ge 
Grand 
total 
0 - 30 87.9% 9.7% 83.4% 9.1% 83.9% 9.5% 85.1% 9.4% 45.0% 
31 - 60 8.1% 13.2% 10.9% 14.9% 9.4% 16.1% 9.5% 14.5% 12.2% 
61 - 90 2.2% 12.4% 3.0% 12.0% 3.5% 13.5% 2.8% 12.5% 8.0% 
91 - 120 1.1% 9.3% 1.6% 9.5% 1.9% 10.4% 1.5% 9.6% 5.8% 
121 - 150 0.3% 7.9% 0.6% 8.8% 0.4% 9.2% 0.4% 8.5% 4.7% 
151 - 180 0.1% 8.1% 0.0% 7.6% 0.3% 7.0% 0.1% 7.7% 4.1% 
181 - 210 0.2% 7.1% 0.1% 6.8% 0.2% 6.5% 0.2% 6.8% 3.7% 
211 - 240 0.1% 6.4% 0.2% 7.0% 0.2% 5.1% 0.2% 6.3% 3.4% 
241 - 270 0.0% 7.2% 0.1% 7.3% 0.1% 6.0% 0.1% 7.0% 3.7% 
271 - 300 0.0% 6.4% 0.1% 6.5% 0.0% 6.2% 0.0% 6.4% 3.4% 
301 - 330 0.1% 6.2% 0.0% 5.3% 0.0% 5.5% 0.0% 5.7% 3.0% 
331 - 360 0.0% 6.1% 0.0% 5.2% 0.0% 4.9% 0.0% 5.5% 2.9% 
Total for 
Year 
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0
% 
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Table 5. Discrimination of the HES model and the EuroSCORE models 
Period Model CABG Valve CABG + Valve 
In hospital HES 80.5% 78.0% 73.9% 
  Rec-ES 78.8% 71.2% 71.6% 
  ES 79.0% 70.9% 71.6% 
  Add-ES 79.2% 70.5% 71.1% 
30 Days HES 78.4% 74.4% 72.2% 
  Rec-ES 78.6% 72.3% 73.2% 
  ES 78.8% 72.2% 73.4% 
  Add-ES 78.9% 71.7% 73.0% 
90 Days HES 82.3% 76.2% 74.0% 
  Rec-ES 78.8% 71.5% 73.7% 
  ES 78.8% 71.3% 73.9% 
  Add-ES 79.0% 71.0% 73.3% 
180 Days HES 80.7% 72.4% 74.6% 
  Rec-ES 78.3% 71.9% 72.8% 
  ES 78.3% 71.9% 72.9% 
  Add-ES 78.0% 71.7% 72.7% 
1 Year HES 76.3% 76.1% 72.0% 
  Rec-ES 75.7% 70.5% 68.8% 
  ES 75.8% 70.5% 68.7% 
  Add-ES 75.2% 70.5% 68.9% 
HES: Hospital Episode Statistics, refers to the administrative dataset from which the risks models have been 
constructed. Rec-ES: Recalibrated EuroSCORE; logES =logistic EuroSCORE; add-ES:  additive EuroSCORE. 
  
The discrimination for the HES model for In-hospital deaths for CABG and CABG+valve is 
similar to the EuroSCORE models (Rec-ES 0.79, logES 0.79, addES 0.79, for CABG) and 
(Rec-ES 0.72, logES 0.72, addES 0.71 for CABG+valve).  For patients undergoing valve 
surgery however, discrimination of the HES model is superior (0.78 vs. 0.71). The c-statistics 
of the EuroSCORE models for longer periods are numerical lower than that of the HES 
model.  
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Table 6 
Observed versus expected deaths by 10 different risk strata.  
In hospital Risk stratification 
Model Strata Expected Observed Patients Exp.Mortality Observed Mortality 
R
ec
al
ib
ra
te
d
 L
o
gi
st
ic
 E
u
ro
SC
O
R
E 1 6.4 16 1180 0.5% 1.4% 
2 6.4 12 424 1.5% 2.8% 
3 6.4 6 275 2.3% 2.2% 
4 6.5 5 206 3.2% 2.4% 
5 6.4 5 153 4.2% 3.3% 
6 6.3 8 115 5.5% 7.0% 
7 6.6 12 91 7.2% 13.2% 
8 6.4 9 62 10.3% 14.5% 
9 6.5 8 46 14.2% 17.4% 
10 6.5 7 29 22.3% 24.1% 
H
ES
 
1 5.2 6 961 0.5% 0.6% 
2 5.3 11 460 1.1% 2.4% 
3 5.2 7 331 1.6% 2.1% 
4 5.2 8 257 2.0% 3.1% 
5 5.3 9 195 2.7% 4.6% 
6 5.2 8 138 3.8% 5.8% 
7 5.3 8 102 5.2% 7.8% 
8 5.3 11 72 7.3% 15.3% 
9 5.2 11 46 11.4% 23.9% 
10 5.3 7 18 29.6% 38.9% 
Risk is stratified by expected deaths to mitigate low counts within each strata 
 
 
Table illustrates the observed versus expected number of deaths for the Recalibrated Logistic 
EuroSCORE model compared to the HES model by risk strata. To avoid reporting restrictions 
due to low numbers the table is partitioned with respect to the expected number of deaths in 
each risk strata. The Recalibrated Logistic EuroSCORE shows over prediction in the lower 
risk strata, and the HES model under-prediction in the higher risk strata, in this limited 
dataset.  
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Discussion 
 
Analysing HES data for NHS England linked to ONS, a large, complete and objective data 
source we have obtained time to death following adult cardiac surgical procedures and have 
produced specific models that have both good discrimination and calibration, and are stable 
over time.   and we believe capture the majority of post procedural deaths.  We have also 
demonstrated that administrative data sets, when used correctly including complete patient 
specific data may be produce risk prediction algorhytm comparablealgorithm comparable to 
those based on large clinically specific registries without some of their potential 
disadvantages.   
 
The HES data is comprehensive of each hospital admission and its level of completeness has 
significantly increased in recent years.  Specialised clinical coders who have to have a 
nationally recognised qualification enter patient level data.  HES data depth of coding, a 
measure of completeness of patient level comorbidity often used as a measure of data quality 
has also improved.  This dataset is used for high profile institutional level national 
governance, by health care quality regulators, forms the basis of reimbursement and is 
regularly audited by independent national auditing bodies.  
 
Clinical registry based data provide the most robust information from which to construct 
disease/clinical specialty specific risk predicting models.  The Society of Thoracic Surgery 
(STS) have suggested that data derived from clinical registries are superior than those derived 
from administrative sources, especially when its models are based upon large and robust data 
sources such as the STS NCD (REF) .  European centres have also demonstrated the 
superiority of clinical registries over administrative data.  A recent Dutch study demonstrated 
significant inferiority of a risk model based on administrative data compared to a clinical 
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model on both model discrimination and calibration thus recommending caution when 
interpreting benchmarking information from administrative data in the Netherlands (REF 
Siregar et al).   
It could be hypothesised that one of the reason for inferiority of previously developed 
administrative registries is that they often tried to replicate the disease specific dataset 
variables that clinical registries collect and then, because of a lack of specific prognostic data 
fields such as: active endocarditis or presence of pulmonary hypertension in the Dutch 
administrative data, the derived risk algorithm may produce and inferior performance.  The 
advantage of large administrative data sets such as the National Health Service Hospital 
Episode Statistics for England, is that it collects information on powerful prognostic 
covariates such as the presence of liver disease, the level of social deprivation, ethnicity, and 
previous hospital admission history which are not usually included in disease specific 
registries (REF our BMJ paper, QURUM model).  It is possible that our approach of 
incorporating this patient specific powerful prognostic information in our models offsets the 
loss of disease specific data such as left ventricular function, degree of coronary artery disease 
which are known to be powerful disease specific prognostic variables normally collected in 
registries.  This is in accord with Lilford’s 2004 study (REF get from heart editorial) that 
suggested that variation in hospital outcomes was a composite of data quality/definitions, 
case-mix healthcare quality and chance i.e. that outcome can be influenced by unmeasured or 
unrecorded factors that carry significant prognostic importance. 
Siregar et al. (REF) reported the difficulty in matching the administrative hospital episodes 
with those recorded in the registries, a well-recognised limitation of such an approach.  In our 
study we found a high level of agreement between registry and HES data (>95%) for the three 
procedure groupings, although this finding is based only on a local registry. Shold this level 
of agreement be demonstrated on a larger dataset, it would suggest that at least at institutional 
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level in England, the HES model could be used for outcome and benchmarking analysis in 
adult cardiac surgery, and a similar approach could be implemented where good quality 
administrative data is available but clinical registries are not well developed. Some national 
governance programme, such as the one in UK  ( REF website SCTS.ORG page on patient 
Outcomes) are using data from clinical registries for surgeon specific outcome monitoring and 
this approach relies on the exact attribution of eligible procedures to a individual practitioner.  
This remains a recognised area for improvement for the HES administrative dataset.  
 
Both the EuroSCORE and the STS scores are affected by a phenomenon called “calibration 
drift” which commonly leads to significant overestimation of the expected mortality end point 
with the time.  This phenomenon has important repercussions, including the over-estimation 
of risk for patients with higher risk profile, thus potentially denying them from surgical 
treatment. Furthermore a model that over predicts risk when used as a benchmarking tool may 
falsely reassure  usreassure us about clinical performance. Calibration drift is due to several 
reasons, which include changes in clinical practice, lack of clarity on variable definitions and 
inaccurate data entry.  One example is that in the original EuroSCORE definition of recent 
myocardial infarction had a significant weight in predicting increased risk of in-hospital death 
following cardiac surgery, in keeping with the significant increase risk of early surgery shown 
in studies such as the VANQUISH trial (REF). The introduction in routine clinical practice of 
high sensitivity Troponin analysis has now changed the threshold for the diagnosis of 
myocardial infarction, and now it includes large numbers of patients with less myocardial 
necrosis and a less risk following surgery. When applying the EuroSCORE definition and its 
original statistical weight to this group it will lead to overestimation of their risk.   
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The commonest method of dealing with calibration drift is to recalibrate the risk model to 
produce an adjustment factor in the equation.  This may need to be done as frequently as 
every year to maintain its accuracy raising concerns over model fit over several adjustments.  
In our study the HES model proved to be stable over two subsequent years after its 
development and in some cases its performance  (C-Statistics) improved which could reflect 
the continuous improvement in the HES dataset. The stability of our risk scoring system, 
which needs to be proven over a longer period of time, could be due to the fact that is based 
on powerful patient level covariates that are well defined and unlikely to change their impact 
on prognosis over a short time as described above.  
The STS have has improved their risk model prediction by developing procedure specific 
models.  They have validated models for CABG, isolated valve and valve + CABG 
procedures, however they models for more specific valve procedures such as mitral valve 
surgery proved difficult to construct (REF STS Valve Model Paper Annals T S).  We have 
followed a similar approach.  In our study, the model fit and its calibration are good for 
isolated CABG surgery (based on 35115 patients’ data) and is good for valve only procedures 
(based on 18353 patient data). The number of patients undergoing combined valve and CABG 
procedures was adequate to construct a further well-calibrated model but a reduction in fit is 
noted for this group, as demonstrated by the difference in c-statistics between construction 
and validation set (ref that STS used).  Whilst “one for all” procedures risk prediction 
algorhytm have been proven to be adequate for overall institutional risk adjusted outcome 
reporting, our findings suggest that patients undergoing more sub-specialised and less 
common procedures such as aortic surgery may need a different approach to both risk 
estimation and quality and outcome benchmarking programs.  
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The EuroSCORE and the STS risk models have been developed to predict early mortality (in 
hospital and / or 30 days).  Whilst this could have been an acceptable approach in the 
pioneering era of cardiac surgery and it remains a common approach for governance and 
institutional benchmarking initiatives, we feel that in modern multi-modality practice, we also 
need to be able to predict the longer-term benefit that should be associated with these 
complex surgical procedures.  In our study we developed tools to predict early and up to one-
year outcomes, and each model was specifically developed for the different mortality 
endpoints.  In doing so we also identified variables that seem to be important for long-term 
prognosis such as the level of social deprivation, as we have previously demonstrated (BMJ 
Paper).  We also found, at least using data from our local institution, that the EuroSCORE 
variables produce a longer-term prediction of similar accuracy, confirming the long-term 
values of its variables.  Longer-term prediction could be improved by linking national 
administrative and clinical registry data, thus potentially identifying a “mixed” set of patient 
variables that underpin a more robust and accurate production on longer term. This approach 
could help to identify patients that are more likely to benefit from cardiac surgery.  
Recently, it has been recognised that there is a need to identify and standardise measurable 
clinically relevant endpoints for each major procedure (VARC-2 Reference EJCTS ). This 
approach is useful for clinical reporting of outcomes, to benchmark like-with-like, for 
designing clinical trials and for patients level outcome estimation.  Historically in 
conventional cardiac surgery early post-procedural mortality (30 days or in-hospital) has been 
used as a standard endpoint. We have previously discussed that this pragmatic approach, at 
least when used for governance may have limitations (Heart Editorial), particularly as it does 
not take into account different practices of discharge among several health care systems thus 
missing some early deaths from the counts. In addition, whilst there might be value in using 
an early end point for institutional based outcome measure, longer-term outcomes may 
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depend more on health care secondary care.  Our time-to-death analysis (Figure 2 and Table 
4) provides information that would help inform a consensus on mortality end-points to be 
used and their potential pitfalls.  
 
In summary we have produced a risk prediction model based on English administrative data, 
which comprises a small list of pronostic variables ( max 10) and allows accurate prediction 
for early and up to one year mortality following cardiac surgery. Our risk model’s 
performance is comparable to that of commonest most risk scoring systems used.  Investing in 
improving the accuracy of national administrative data could may provide a more cost 
effective platform to underpin quality improvement programmes in several many clinical 
specialties. Future research is necessary to develop tools to predict more accurately serious 
complications and morbidity, which may include the use of new predictors including genetic 
profiling (REF Duke paper), in order to aid correct interventional decisions in an era of 
multimodality approach.  
 
. 
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